Financhill
Sell
28

UTMD Quote, Financials, Valuation and Earnings

Last price:
$55.97
Seasonality move :
1.69%
Day range:
$55.86 - $56.50
52-week range:
$51.26 - $65.56
Dividend yield:
2.19%
P/E ratio:
15.83x
P/S ratio:
4.76x
P/B ratio:
1.52x
Volume:
10.1K
Avg. volume:
15.9K
1-year change:
-8.96%
Market cap:
$179.3M
Revenue:
$40.9M
EPS (TTM):
$3.53
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $42.2M $49.1M $52.3M $50.2M $40.9M
Revenue Growth (YoY) -10.08% 16.3% 6.58% -3.94% -18.56%
 
Cost of Revenues $16.6M $24.8M $26.5M $25.9M $18.8M
Gross Profit $25.5M $24.3M $25.8M $24.3M $22.1M
Gross Profit Margin 60.57% 49.48% 49.31% 48.48% 53.98%
 
R&D Expenses $486K $526K $493K $560K $813K
Selling, General & Admin $11.4M $11.5M $11.9M $12.7M $9.7M
Other Inc / (Exp) $132K $181K $869K $3.3M $3.2M
Operating Expenses $11.8M $5.4M $5.3M $5.9M $6.3M
Operating Income $13.7M $18.9M $20.5M $18.4M $15.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $13.8M $19.1M $20.7M $20.1M $16.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3M $4.3M $4.2M $3.5M $2.9M
Net Income to Company $10.8M $14.8M $16.5M $16.6M $13.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10.8M $14.8M $16.5M $16.6M $13.9M
 
Basic EPS (Cont. Ops) $2.95 $4.05 $4.53 $4.58 $3.96
Diluted EPS (Cont. Ops) $2.94 $4.04 $4.52 $4.57 $3.96
Weighted Average Basic Share $3.7M $3.6M $3.6M $3.6M $3.5M
Weighted Average Diluted Share $3.7M $3.7M $3.6M $3.6M $3.5M
 
EBITDA $20.9M $26.2M $27.5M $24.8M $18.6M
EBIT $13.7M $18.9M $20.5M $18.4M $15.7M
 
Revenue (Reported) $42.2M $49.1M $52.3M $50.2M $40.9M
Operating Income (Reported) $13.7M $18.9M $20.5M $18.4M $15.7M
Operating Income (Adjusted) $13.7M $18.9M $20.5M $18.4M $15.7M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $12.6M $13M $12.5M $10M $9.8M
Revenue Growth (YoY) 19.97% 3.05% -3.47% -19.99% -1.93%
 
Cost of Revenues $6.2M $6.3M $6.8M $4.7M $4.8M
Gross Profit $6.4M $6.6M $5.7M $5.3M $5.1M
Gross Profit Margin 51% 50.99% 45.92% 52.74% 51.56%
 
R&D Expenses $127K $112K $138K $172K $167K
Selling, General & Admin $2.8M $2.9M $3.3M $2.3M $2.8M
Other Inc / (Exp) $59K $198K $812K $836K --
Operating Expenses $1.3M $1.5M $1.8M $1.9M $2.4M
Operating Income $5.1M $5.1M $4M $3.3M $2.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $5.2M $5.3M $4.8M $4.2M $3.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $951K $1.1M $846K $616K $678K
Net Income to Company $4.2M $4.3M $3.9M $3.6M $2.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.2M $4.3M $3.9M $3.6M $2.6M
 
Basic EPS (Cont. Ops) $1.15 $1.18 $1.08 $1.02 $0.82
Diluted EPS (Cont. Ops) $1.15 $1.18 $1.08 $1.02 $0.82
Weighted Average Basic Share $3.6M $3.6M $3.6M $3.5M $3.2M
Weighted Average Diluted Share $3.7M $3.6M $3.6M $3.5M $3.2M
 
EBITDA $6.9M $6.9M $5.8M $4.1M $3.4M
EBIT $5.1M $5.1M $4M $3.3M $2.6M
 
Revenue (Reported) $12.6M $13M $12.5M $10M $9.8M
Operating Income (Reported) $5.1M $5.1M $4M $3.3M $2.6M
Operating Income (Adjusted) $5.1M $5.1M $4M $3.3M $2.6M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $48.2M $51.6M $51.5M $44.1M $38.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $24.7M $26.1M $26.6M $20.6M $18.7M
Gross Profit $23.4M $25.5M $24.9M $23.5M $20M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $496K $511K $538K $839K $577K
Selling, General & Admin $11.5M $11.6M $12.8M $10.5M $9.6M
Other Inc / (Exp) $136K $399K $2.4M $2.8M --
Operating Expenses $5.4M $5.6M $7M $8.9M $8.1M
Operating Income $18M $19.9M $17.9M $14.6M $11.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $18.2M $20.2M $20.7M $18.2M $14.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.1M $4.2M $3.8M $2.9M $3M
Net Income to Company $14.1M $16.1M $16.9M $15.3M $11.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $14.1M $16M $16.9M $15.3M $11.6M
 
Basic EPS (Cont. Ops) $3.86 $4.41 $4.66 $4.28 $3.54
Diluted EPS (Cont. Ops) $3.85 $4.39 $4.65 $4.28 $3.53
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $25.4M $27M $25M $17.8M $14.9M
EBIT $18M $19.9M $17.9M $14.6M $11.9M
 
Revenue (Reported) $48.2M $51.6M $51.5M $44.1M $38.6M
Operating Income (Reported) $18M $19.9M $17.9M $14.6M $11.9M
Operating Income (Adjusted) $18M $19.9M $17.9M $14.6M $11.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $36.1M $38.7M $37.9M $31.7M $29.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $15M $19.7M $19.8M $14.5M $14.3M
Gross Profit $21.1M $19M $18.1M $17.3M $15.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $385K $370K $415K $693K $456K
Selling, General & Admin $8.7M $8.8M $9.7M $7.5M $7.3M
Other Inc / (Exp) $129K $348K $1.8M $1.8M $391K
Operating Expenses $7.4M $4.3M $5.3M $6.6M $6.2M
Operating Income $13.8M $14.7M $12.8M $10.7M $9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $13.9M $15.1M $15.1M $13.2M $11M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.2M $3.2M $2.7M $2.2M $2.3M
Net Income to Company $10.7M $11.9M $12.3M $11M $8.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10.7M $11.9M $12.3M $11M $8.7M
 
Basic EPS (Cont. Ops) $2.92 $3.27 $3.40 $3.10 $2.68
Diluted EPS (Cont. Ops) $2.92 $3.27 $3.39 $3.10 $2.68
Weighted Average Basic Share $10.9M $10.9M $10.9M $10.6M $9.8M
Weighted Average Diluted Share $11M $10.9M $10.9M $10.6M $9.8M
 
EBITDA $19.3M $20.1M $18.2M $12.8M $11.2M
EBIT $13.8M $14.7M $12.8M $10.7M $9M
 
Revenue (Reported) $36.1M $38.7M $37.9M $31.7M $29.5M
Operating Income (Reported) $13.8M $14.7M $12.8M $10.7M $9M
Operating Income (Adjusted) $13.8M $14.7M $12.8M $10.7M $9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $51.6M $61M $75.1M $92.9M $83M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.2M $5.1M $5.5M $3.4M $4.1M
Inventory $6.2M $6.6M $8.8M $9.6M $8.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $346K $457K $515K $429K $448K
Total Current Assets $62.3M $73.2M $89.9M $106.3M $96.3M
 
Property Plant And Equipment $11.3M $11.1M $10.2M $10.6M $9.8M
Long-Term Investments -- -- -- -- --
Goodwill $14.2M $14.1M $13.4M $13.7M $13.6M
Other Intangibles $24M $17.8M $10.4M $4.9M $2.9M
Other Long-Term Assets -- -- -- -- --
Total Assets $111.7M $115.6M $123.9M $135.5M $122.5M
 
Accounts Payable $788K $761K $1.2M $769K $696K
Accrued Expenses $2.9M $2.9M $4.2M $3.4M $3.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.8M $3.7M $6M $4.7M $3.8M
 
Long-Term Debt -- $396K $341K $295K $282K
Capital Leases -- -- -- -- --
Total Liabilities $8.9M $8.5M $9.6M $7.1M $5.1M
 
Common Stock $36K $37K $36K $36K $33K
Other Common Equity Adj -$8.3M -$9.1M -$12M -$10.7M -$11.9M
Common Equity $102.8M $107.1M $114.3M $128.3M $117.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $102.8M $107.1M $114.3M $128.3M $117.4M
 
Total Liabilities and Equity $111.7M $115.6M $123.9M $135.5M $122.5M
Cash and Short Terms $51.6M $61M $75.1M $92.9M $83M
Total Debt -- $396K $341K $295K $282K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $64.3M $69.5M $88.2M $88.5M $84.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.9M $6M $3.5M $3.7M $3.7M
Inventory $6.3M $8.3M $9.7M $9.1M $8.1M
Prepaid Expenses -- -- -- -- --
Other Current Assets $373K $387K $442K $377K --
Total Current Assets $75.8M $84.2M $101.8M $101.7M $96.5M
 
Property Plant And Equipment $10.9M $10.3M $10.3M $10.4M $10M
Long-Term Investments -- -- -- -- --
Goodwill $14.1M $12.9M $13.4M $14M --
Other Intangibles $18.9M $11M $5.6M $3.6M --
Other Long-Term Assets -- -- -- -- --
Total Assets $119.8M $118.4M $131.2M $129.7M $122M
 
Accounts Payable $1M $1.3M $511K $999K $768K
Accrued Expenses $4M $5M $3.7M $2.4M --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5M $6.3M $4.2M $3.4M $3M
 
Long-Term Debt $343K $354K $305K $299K $241K
Capital Leases -- -- -- -- --
Total Liabilities $9.8M $10.2M $7.5M $5.5M $3.7M
 
Common Stock $36K $36K $36K $34K $32K
Other Common Equity Adj -$9.1M -$14.4M -$12M -$9.9M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $110M $108.2M $123.7M $124.2M $118.3M
 
Total Liabilities and Equity $119.8M $118.4M $131.2M $129.7M $122M
Cash and Short Terms $64.3M $69.5M $88.2M $88.5M $84.3M
Total Debt $343K $354K $305K $299K $241K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $10.8M $14.8M $16.5M $16.6M $13.9M
Depreciation & Amoritzation $7.2M $7.3M $7.1M $6.4M $2.8M
Stock-Based Compensation $160K $166K $183K $225K $256K
Change in Accounts Receivable $662K -$1.1M -$525K $2.3M -$781K
Change in Inventories $924K -$485K -$2.4M -$670K $587K
Cash From Operations $20.1M $21.2M $21.1M $22.3M $14.8M
 
Capital Expenditures $860K $552K $818K $639K $235K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$860K -$552K -$818K -$639K -$208K
 
Dividends Paid (Ex Special Dividend) -$4.1M $11.5M $3.2M $4.3M $4.3M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$7M -- $2.5M -- $20M
Other Financing Activities -- -- -- -- --
Cash From Financing -$10.7M -$10.9M -$5.5M -$4.2M -$23.8M
 
Beginning Cash (CF) $42.8M $61M $75.1M $92.9M $83M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $8.5M $9.4M $14.1M $17.8M -$9.9M
Ending Cash (CF) $51.6M $70M $88.4M $111M $72.4M
 
Levered Free Cash Flow $19.3M $20.7M $20.3M $21.6M $14.6M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $4.2M $4.3M $3.9M $3.6M $2.6M
Depreciation & Amoritzation $1.8M $1.7M $1.8M $740K $769K
Stock-Based Compensation $41K $38K $53K $53K $94K
Change in Accounts Receivable -$285K -$1.2M $89K -$9K -$506K
Change in Inventories -$236K -$1.1M $320K $67K $101K
Cash From Operations $6M $5.6M $5.1M $3.9M $3.9M
 
Capital Expenditures $77K $321K $186K $89K $27K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$77K -$321K -$186K -$89K -$27K
 
Dividends Paid (Ex Special Dividend) $1M $1.1M $1.1M $1.1M $988K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- $3.9M $653K
Other Financing Activities -- -- -- -- --
Cash From Financing -$850K -$1M -$1M -$4.9M -$1.6M
 
Beginning Cash (CF) $64.3M $69.5M $88.2M $88.5M $84.3M
Foreign Exchange Rate Adjustment -$249K -$949K -$310K $384K -$122K
Additions / Reductions $4.8M $3.3M $3.6M -$767K $2.1M
Ending Cash (CF) $68.9M $71.8M $91.5M $88.1M $86.2M
 
Levered Free Cash Flow $5.9M $5.3M $4.9M $3.8M $3.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $14.1M $16.1M $16.9M $15.3M $11.6M
Depreciation & Amoritzation $7.3M $7.1M $7.1M $3.2M $3M
Stock-Based Compensation $162K $164K $215K $256K $334K
Change in Accounts Receivable -$582K -$1.4M $2.7M -$169K -$572K
Change in Inventories $6K -$2.4M -$1.2M $763K $1.1M
Cash From Operations $22M $20.5M $22.6M $17.2M $14.2M
 
Capital Expenditures $353K $1M $587K $316K $271K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$353K -$1M -$587K -$289K -$271K
 
Dividends Paid (Ex Special Dividend) $4.1M $10.5M $4.3M $4.3M $4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$1K $2.5M -- $13.3M $14.1M
Other Financing Activities -- -- -- -- --
Cash From Financing -$3.8M -$12.6M -$4M -$17.2M -$18.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18M $5.2M $18.7M $243K -$4.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $21.6M $19.4M $22M $16.9M $13.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $10.7M $11.9M $12.3M $11M $8.7M
Depreciation & Amoritzation $5.5M $5.3M $5.3M $2.1M $2.2M
Stock-Based Compensation $123K $121K $153K $184K $262K
Change in Accounts Receivable -$802K -$1.1M $2.1M -$306K -$97K
Change in Inventories -$161K -$2.1M -$925K $508K $1M
Cash From Operations $16.2M $15.5M $16.9M $11.9M $11.2M
 
Capital Expenditures $299K $780K $549K $226K $262K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$299K -$780K -$549K -$199K -$262K
 
Dividends Paid (Ex Special Dividend) -$1M $2.1M $3.2M $3.2M $3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- $2.5M -- $13.3M $7.4M
Other Financing Activities -- -- -- -- --
Cash From Financing -$2.8M -$4.6M -$3.1M -$16.1M -$10.4M
 
Beginning Cash (CF) $171.9M $201.6M $253.7M $271.5M $249.8M
Foreign Exchange Rate Adjustment -$351K -$1.6M -$149K -$20K $705K
Additions / Reductions $12.8M $8.5M $13.2M -$4.4M $1.3M
Ending Cash (CF) $184.4M $208.6M $266.7M $267M $251.8M
 
Levered Free Cash Flow $15.9M $14.7M $16.4M $11.7M $11M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock